Low-dose Interleukin-2 in Women With Unexplained Miscarriages

Summary

The purpose of this study is to demonstrate the ability of low dose IL-2 to stimulate peripheral blood Tregs of women with unexplained repeated early spontaneous miscarriages for development of a therapy to prevent fetal rejection by low dose IL-2.

Timeline

Start

2021-01-05

Primary completion

2023-07-28

Completion

2024-03-20

Drugs

Indications